| |
| |
|
| Insider
Information: |
Loberg Michael D |
| Relationship: |
Director |
| City: |
Bedford |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
9,138 |
|
|
Indirect Shares
|
81,790 |
|
|
| Direct
Value |
$110,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
90,928 |
|
|
| Total
Value |
$110,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2006-06-08 |
8,000 |
2006-06-07 |
0 |
Premium* |
|
|
Arqule Inc |
ARQL |
Director |
2020-01-16 |
0 |
2007-08-17 |
0 |
Premium* |
|
|
Igm Biosciences, Inc. |
IGMS |
Director |
2023-09-29 |
1,138 |
2023-09-29 |
81,790 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
262 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQL |
Arqule Inc |
Director |
– • – |
2015-05-18 |
4 |
A |
$1.85 |
$3,125 |
D/D |
1,689 |
118,636 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-02-18 |
4 |
A |
$1.85 |
$3,125 |
D/D |
1,689 |
134,984 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2012-11-16 |
4 |
A |
$2.36 |
$4,123 |
D/D |
1,747 |
76,704 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2014-09-23 |
4 |
A |
$1.14 |
$2,000 |
D/D |
1,754 |
104,105 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-11-14 |
4 |
B |
$2.84 |
$5,108 |
D/D |
1,800 |
17,552 |
2.39 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2015-08-18 |
4 |
A |
$1.70 |
$3,125 |
D/D |
1,838 |
122,740 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-05-18 |
4 |
A |
$1.59 |
$3,124 |
D/D |
1,965 |
139,779 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-08-18 |
4 |
A |
$1.53 |
$3,124 |
D/D |
2,042 |
144,142 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2014-05-16 |
4 |
A |
$1.46 |
$3,124 |
D/D |
2,140 |
96,114 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2016-11-18 |
4 |
A |
$1.40 |
$3,125 |
D/D |
2,232 |
150,617 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2014-08-18 |
4 |
A |
$1.34 |
$3,125 |
D/D |
2,332 |
101,375 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2017-05-18 |
4 |
A |
$1.22 |
$3,124 |
D/D |
2,561 |
160,701 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2017-02-18 |
4 |
A |
$1.20 |
$3,125 |
D/D |
2,604 |
155,171 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2015-02-18 |
4 |
A |
$1.38 |
$4,373 |
D/D |
3,169 |
114,595 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2014-11-18 |
4 |
A |
$1.28 |
$4,124 |
D/D |
3,222 |
108,987 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2015-12-17 |
4 |
B |
$2.16 |
$8,030 |
D/D |
3,719 |
132,142 |
2.39 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2019-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,539 |
39,803 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2019-09-18 |
4 |
B |
$18.57 |
$92,867 |
D/D |
5,000 |
35,264 |
2.39 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-09-29 |
4 |
B |
$19.62 |
$114,213 |
I/I |
5,821 |
35,305 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-09-28 |
4 |
B |
$20.97 |
$129,403 |
I/I |
6,172 |
29,484 |
2.1 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2006-06-05 |
4 |
S |
$24.02 |
$192,127 |
D/D |
(8,000) |
0 |
|
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2008-11-13 |
4 |
B |
$2.87 |
$27,850 |
D/D |
9,710 |
15,752 |
2.39 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2006-05-11 |
5 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
0 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2019-04-10 |
4 |
OE |
$3.87 |
$38,700 |
D/D |
10,000 |
172,514 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-04-01 |
4 |
B |
$23.00 |
$499,997 |
I/I |
21,739 |
21,739 |
2.1 |
- |
|
262 Records found
|
|
Page 10 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
